Detalhe da pesquisa
1.
SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
J Immunol
; 207(3): 878-887, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34301847
2.
Characterization of SARS-CoV-2 humoral immune response in a subject with unique sampling: A case report.
Immun Inflamm Dis
; 11(6): e910, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382252
3.
SARS-CoV-2 RBD-Specific Antibodies Induced Early in the Pandemic by Natural Infection and Vaccination Display Cross-Variant Binding and Inhibition.
Viruses
; 14(9)2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146667
4.
Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells.
Viruses
; 13(4)2021 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33806155
5.
Site-specific O-glycosylation analysis of SARS-CoV-2 spike protein produced in insect and human cells.
bioRxiv
; 2021 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33564762
6.
Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants.
mBio
; 12(5): e0181321, 2021 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34634927
7.
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity.
Nat Commun
; 12(1): 324, 2021 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33436573
8.
Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.
Cells
; 8(9)2019 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31466397
9.
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody.
Nat Commun
; 9(1): 3822, 2018 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30237518